The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(7-Ethoxy-3-ethyl-1H-indazole-5-carbonyl)-2'-ethyl-3'-methyl-2'H-spiro[piperidine-4,5'-pyrano[3,2,c]pyrazol]-7'(6'H)-one ID: ALA1958366
PubChem CID: 56949652
Max Phase: Preclinical
Molecular Formula: C25H31N5O4
Molecular Weight: 465.55
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCOc1cc(C(=O)N2CCC3(CC2)CC(=O)c2nn(CC)c(C)c2O3)cc2c(CC)n[nH]c12
Standard InChI: InChI=1S/C25H31N5O4/c1-5-18-17-12-16(13-20(33-7-3)21(17)27-26-18)24(32)29-10-8-25(9-11-29)14-19(31)22-23(34-25)15(4)30(6-2)28-22/h12-13H,5-11,14H2,1-4H3,(H,26,27)
Standard InChI Key: KVIDGDZPLJQYIN-UHFFFAOYSA-N
Molfile:
RDKit 2D
34 38 0 0 0 0 0 0 0 0999 V2000
1.0500 -1.3917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0507 -2.2167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7615 -2.6263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4763 -2.2155 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4756 -1.3905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7602 -0.9763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3412 -1.8000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.0532 -0.5667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3412 -0.1500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3708 -1.3917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3708 -0.5621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1598 -0.3057 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.6475 -0.9768 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.1598 -1.6479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1905 -2.6284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1900 -3.4534 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.9052 -2.2164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6151 -2.6312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6110 -0.9812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8998 -1.3949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1086 -2.4768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5966 -1.8132 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.1158 -1.1436 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3303 -1.3939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3256 -2.2183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3432 0.6750 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.4725 -0.9768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8850 -0.2623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4148 -2.4325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6086 -0.1562 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.3218 0.2584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3194 1.0834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5201 -3.1919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3451 -3.1932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15 16 2 0
11 9 1 0
15 17 1 0
10 7 1 0
17 18 2 0
18 25 1 0
7 1 1 0
24 19 1 0
1 8 1 0
19 20 2 0
20 17 1 0
24 25 2 0
8 9 1 0
10 11 1 0
22 23 1 0
2 3 1 0
3 4 1 0
4 5 1 0
21 22 2 0
23 24 1 0
25 21 1 0
5 6 1 0
9 26 2 0
13 27 1 0
11 12 2 0
27 28 1 0
12 13 1 0
14 29 1 0
13 14 1 0
19 30 1 0
14 10 2 0
30 31 1 0
1 2 1 0
31 32 1 0
4 15 1 0
21 33 1 0
1 6 1 0
33 34 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 465.55Molecular Weight (Monoisotopic): 465.2376AlogP: 3.69#Rotatable Bonds: 5Polar Surface Area: 102.34Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.26CX Basic pKa: 2.83CX LogP: 2.07CX LogD: 2.07Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.62Np Likeness Score: -1.22
References 1. Freeman-Cook KD, Amor P, Bader S, Buzon LM, Coffey SB, Corbett JW, Dirico KJ, Doran SD, Elliott RL, Esler W, Guzman-Perez A, Henegar KE, Houser JA, Jones CS, Limberakis C, Loomis K, McPherson K, Murdande S, Nelson KL, Phillion D, Pierce BS, Song W, Sugarman E, Tapley S, Tu M, Zhao Z.. (2012) Maximizing lipophilic efficiency: the use of Free-Wilson analysis in the design of inhibitors of acetyl-CoA carboxylase., 55 (2): [PMID:22148323 ] [10.1021/jm201503u ]